Calcium Blocker Diltiazem Inhibits Platelet Activation and Stimulates Vascular Prostacyclin Synthesis
Open Access
- 1 January 1986
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 291 (1) , 20-24
- https://doi.org/10.1097/00000441-198601000-00005
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of verapamil on platelet aggregation, ATP release and thromboxane generationThrombosis Research, 1983
- Effects of peripheral vasodilation caused by Verapamil, nifedipine, and nitroglycerin on plasma prostaglandins and thromboxane concentrations.Japanese Heart Journal, 1982
- Effect of diltiazem in patients with variant angina: A randomized double-blind trialAmerican Heart Journal, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Effects by nifedipine (Adalat®) on platelet function in vitro and in vivoThrombosis Research, 1981
- Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical ApplicationsAnnals of Internal Medicine, 1980
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- In vitro effect of the coronary vasodilator diltiazem on human and rabbit plateletsThrombosis Research, 1978
- Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranolol.Circulation, 1978
- Coronary Tone Modulation: Formation and Actions of Prostaglandins, Endoperoxides, and ThromboxanesScience, 1977